Live Breaking News & Updates on Bharat Biotech Drv Krishna Mohan

COVID-19 vaccine: SII, Bharat Biotech to raise production by August
While Pune-based Serum Institute said it can ramp up the production to 10 crore, the Hyderabad-based Bharat Biotech said they can raise the production to 7.8 crore doses till August
BusinessToday.In | May 13, 2021 | Updated 09:33 IST
Serum Institute of India and Bharat Biotech have submitted their production plan for the next four months as several states continue to report the shortages of COVID-19 vaccines.
While Pune-based Serum Institute said it can ramp up the production to 10 crore, the Hyderabad-based Bharat Biotech said they can raise the production to 7.8 crore doses till August.
Whole-time Director of Bharat Biotech Dr V Krishna Mohan told the Union Health Ministry and the office of Drugs Controller General of India (DCGI) that the production of Covaxin can be raised to 3.32 crore in July and 7.82 crore in August, which will also be maintained in September. ....

Uttar Pradesh , Andhra Pradesh , V Krishna Mohan , Union Health Ministry , Department Of Pharmaceuticals Rajneesh Tingal , While Serum Institute , Serum Institute Of India , Ministry Of Science , Health Ministry Dr Mandeep Bhandari , Serum Institute , Bharat Biotech , Pune Based Serum Institute , Hyderabad Based Bharat Biotech , Bharat Biotech Drv Krishna Mohan , Drugs Controller General , Regulatory Affairs , Serum Institute Prakash Kumar Singh , Joint Secretary , Pharmaceuticals Rajneesh Tingal , Covid 19 Vaccine , Covid 19 Vaccine Production , Serum Institute Of India Covid 19 Vaccine , Bharat Biotech Covid 19 Vaccine , Sii Covid 19 Vaccine , Serum Institute Covid 19 Vaccine , Serum Institute Of Ind ,